Skip to content
活动家资讯

活动家资讯

传递会议价值_深度行业分析

  • 商务会议
  • 游学
    • 国内标杆
    • 海外考察
  • 国际展会
  • 会议资讯
  • 演讲嘉宾
  • 发布活动
  • 订单查询

MariondeJong简历_MariondeJong受邀参会演讲_活动家

Posted on 2021年5月28日 By 活动家编辑小助手

Marion de Jong, Ph.D., is a Professor of Nuclear Biology at the Departments of Nuclear Medicine and Radiology at Erasmus MC in Rotterdam/The Netherlands. She got her PhD degree in 1993 at the Erasmus MC. She is the chair of the SPECTRIM group in molecular imaging and therapy, she was promoted as professor in 2006. Marion de Jong has (co)published more than 300 peer-reviewed papers in international journals (H-Index is 54), holds several patents, obtained many grants and she, as well as her team members, received numerous awards. She was promotor (supervisor) of > 30 past and current PhD students. She is chair of the Translational Molecular Imaging Committee of the European Association of Nuclear Medicine (EANM), member of the Molecular Imaging Committee for the European Society of Radiology, Vice chair of the Nantes Cyclotron (Arronax) Scientific Committee, Member of the national VIDI committee and Chair of the Expert Committee of the Animal Imaging Facility at Erasmus MC. Her major scientific interests include: 1) Translational imaging and radionuclide therapy of tumours and other lesions using theranostic radiopharmaceuticals, with a focus on radiolabelled peptides, and 2) Translational molecular imaging of lesions with focus on nuclear imaging, also in combination with CT, optical imaging and MRI. Selective receptor-targeting radiopeptides have emerged as a very important class of radiopharmaceuticals for molecular imaging and therapy of tumours that overexpress peptide receptors on the cell membrane. After such peptides labeled with diagnostic radionuclides bind to their receptors, they allow visualization of receptor-expressing tumors non-invasively. Peptides labeled with therapeutic beta- or alpha-particle emitters can eradicate receptor-expressing tumors. Erasmus MC has been a pioneer in this field and is still at the forefront of the research field. In the clinic we imaged over 5000 patients using radiolabelled somatostatin analogues, whereas over 1500 treatments were given. Our efforts now concentrate on widening the therapeutic window by combination therapy, increasing the tumour radiation dose and/or decreasing the dose to the normal, healthy, organs. Finally, we aim at curing these now incurable metastasized cancers. To enlarge the panel of tumours to be imaged and treated, we also design and evaluate analogues of other peptides, including bombesin, CCK, and neurotensin analogues that bind to their receptors in a variety of different tumours.

活动家是第三方嘉宾邀约平台。可根据演讲议题、会议日期、活动预算等要求,为您提供该领域内专业嘉宾演讲邀约服务,专家学者嘉宾远程视频分享发言,祝福致辞视频拍摄,网红明星艺人VCR活动录制,代言邀约,企业家国际顾问咨询服务。您可准备好活动信息后,联系电话:18911802888(王老师)(工作日9时至18时,仅邀约嘉宾出席活动,其他需求勿扰)

演讲嘉宾

文章导航

Previous Post: 张杨简历_X浙江大学博士生导师张杨受邀参会演讲_活动家
Next Post: 王维夫简历_微神马科技合规部负责人王维夫受邀参会演讲_活动家

More Related Articles

张剑君简历_武钢研究院炼钢所张剑君受邀参会演讲_活动家 演讲嘉宾
陈静奋简历_南京军区联勤部三八保育院教研主任陈静奋受邀参会演讲_活动家 演讲嘉宾
Ken Merdan简历_波士顿科学美国资深研发院士Ken Merdan受邀参会演讲_活动家 演讲嘉宾
许怀哲简历_解决网CEO许怀哲受邀参会演讲_活动家 演讲嘉宾
RemusV.Hotca简历_Molex工业产品事业部全球产品与应用经理RemusV.Hotca受邀参会演讲_活动家 演讲嘉宾
Amy简历_SingtelDataSpark高级分析部门负责人Amy受邀参会演讲_活动家 演讲嘉宾
  • 跑会指南
  • 演讲嘉宾
  • 会议报道
  • 商业资讯
  • IT互联网
  • 金融财经
  • 医疗医学
  • 能源化工
  • 农林牧渔
  • 综合行业
  • 区块链

手机购票

近期文章

  • 第二届图像处理、智能控制与计算机工程国际学术会议(IPICE 2025)
  • 2025年第四届服务机器人国际会议 (ICoSR 2025)
  • 2025年第四届信息与通信工程国际会议(JCICE 2025)
  • 2025中国医药CIO年会暨第2届中国医药AI大模型应用大会
  • 国际分子生物学与进化学会2025年学术年会
  • 2025中国研究型医院大会
  • 2025年第二届计算语言学与自然语言处理国际会议(CLNLP 2025)
  • 2025 物流与供应链管理国际会议 (CoLSCM 2025)
  • 第六届护理与保健国际研讨会 (ICNH 2025)
  • 第五届胶体与界面化学国际研讨会(CIC 2025)

猜你喜欢

运维 移动互联网 云计算 人工智能 消费金融 UWB专利 投融资 FinTech 医药 网络安全 大数据 Chengkok 创业创新 架构 跨境电商物联网 智慧医疗 环保 生物技术智能制造 零售业 新能源汽车 活动家
活动家资讯

蜀ICP备17005018-3号

Copyright © 2025 活动家资讯.

Powered by PressBook Blog WordPress theme